Practical Tips
LDL-C remains the primary target in the guidelines. Clinicians would be encouraged to be familiar with the use of LDL-C and one of the two alternate targets.
We do not advocate using all 3 indices regularly or testing for LDL-C, non-HDL-C and apo B concurrently in subjects.
For those who have apo B available and are comfortable with using it, there are advantages that were previously addressed.